Novo Nordisk

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

Associated Press

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

Associated Press

Sen. Bernie Sanders: U.S. is ‘cash cow’ for maker of blockbuster weight-loss drugs

By Tom Howell Jr. - The Washington Times

Drugs for obesity could be used as a primary prevention tool for heart attacks, new study says

By Brad Matthews - The Washington Times

Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut

By Will Weissert - Associated Press

FDA says counterfeit Ozempic shots are being sold through some legitimate sources

By Jonel Aleccia - Associated Press

No more needles? A daily pill may work as well as Wegovy shots to treat obesity

By Jonel Aleccia - Associated Press

House report: Top drugmakers spend more on investor perks than R&D

By Tom Howell Jr. - The Washington Times

Most Medicare enrollees could get insulin for $35 a month

By RICARDO ALONSO-ZALDIVAR - Associated Press

Bipartisan bill would cap insulin costs in Connecticut

By SUSAN HAIGH - Associated Press

FDA approves diabetes drug that also helps with weight loss

By BY LINDA A. JOHNSON - Associated Press

Danish drug maker Novo Nordisk to lay off 1,000 employees

Associated Press

Ganassi partners with diabetes group

By JENNA FRYER - Associated Press

Paula Deen deflects ‘hypocrisy’ charge

By Leanne Italie - Associated Press

Paula Deen pledges money to diabetes association

By LEANNE ITALIE - Associated Press

Chef Paula Deen hid diabetes, pushed high-fat food

By LEANNE ITALIE - Associated Press

Ganassi signs IndyCar sponsor for Charlie Kimball

By JENNA FRYER - Associated Press

Dive Deeper

Threat Status: Could a perfect storm of controversies reignite South Korean anti-Americanism?

Get Wednesday’s top stories in under five minutes Listen to the Front Page Podcast

Politically Unstable: The man China wants to erase Sebastien Lai joins Kelly Sadler

Threat Status: The race for drone dominance Bill Gertz reports

Latest Stories

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

Sen. Bernie Sanders: U.S. is ‘cash cow’ for maker of blockbuster weight-loss drugs

Drugs for obesity could be used as a primary prevention tool for heart attacks, new study says

Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut

FDA says counterfeit Ozempic shots are being sold through some legitimate sources

No more needles? A daily pill may work as well as Wegovy shots to treat obesity

House report: Top drugmakers spend more on investor perks than R&D

Most Medicare enrollees could get insulin for $35 a month

Bipartisan bill would cap insulin costs in Connecticut

FDA approves diabetes drug that also helps with weight loss

Danish drug maker Novo Nordisk to lay off 1,000 employees

Ganassi partners with diabetes group

Paula Deen deflects ‘hypocrisy’ charge

Paula Deen pledges money to diabetes association

Chef Paula Deen hid diabetes, pushed high-fat food

Ganassi signs IndyCar sponsor for Charlie Kimball